Efficacy of LoDoCo in Improving Exercise Capacity Among Patients With HFpEF and Inflammation

NCT06130059 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

60

Enrollment

OTHER

Sponsor class

Conditions

Heart Failure
Inflammation

Interventions

DRUG: Low Dose Colchicine
DRUG: Placebo

Sponsor

University of Texas Southwestern Medical Center